AIM/BXP (AIM/BXP)

London Stock Exchange AIM: AIM/BXP · GBX

GBX 52.7

+1.17 (+2.3%)· Recorded snapshot

Market cap	386.7M
Revenue (ttm)	333M
Net income (ttm)	53.4M
EPS (ttm)	GBX 0.07
P/E (trailing)	7.4x
P/E (forward)	7.4x
Dividend	GBX 0.02 (4.41%)
Volume	15,000

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 333M
Net income (ttm): 53.4M
EPS (ttm): GBX 0.07
P/E (trailing): 7.4x
P/E (forward): 7.4x
Market cap: 386.7M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E7.4

P25 n/aP50 n/aP75 n/a

Trailing P/E7.4

P25 n/aP50 n/aP75 n/a

ROE14.7

P25 n/aP50 n/aP75 n/a

ROIC14.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All AIM/BXP indicators

Market & fundamental data

Available fields

249

Groups with data

Currency

BDT

Showing 249 of 249 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	GBP
Country	Bangladesh
Country code	UK
Earnings date	2026-11-03
Employees	1,223
Employees change	112
Employees growth	11.09%
Enterprise value	GBX 395.4M
Exchange	London Stock Exchange AIM
Financial currency	BDT
Financial report date	2026-03-31
First seen	2026-05-10
Fiscal year end	June
Founded	1976
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	US0885792061
Last earnings date	2026-01-27
Last refreshed	2026-10-28
Last stock split date	2020-11-23
Last stock split type	Forward
Market cap	GBX 386.7M
Next earnings date	2026-11-03
Price	GBX 52.67
Price currency	GBX
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	aim/BXP
Website	https://beximcopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	12.81x
Average P/E ratio (3Y)	8.47x
Average P/E ratio (5Y)	11.06x
Earnings yield	13.56%
EV/Earnings	7.4x
EV/EBIT	5.76x
EV/EBITDA	4.94x
EV/FCF	8.84x
EV/Sales	1.21x
FCF / EV yield	11.31%
FCF yield	11.56%
Forward P/E	7.36x
Graham number	93.933
Graham upside	78.34%
Industry forward P/E	16.62x
Industry P/E	20.6x
Lynch fair value	GBX 98.70
Lynch upside	87.39%
P/B ratio	0.98x
P/E ratio	7.38x
P/FCF ratio	8.65x
P/OCF ratio	5.98x
P/S ratio	1.16x
Price / tangible book value	1.15x
Price/EBITDA ratio	4.78x
Sector forward P/E	14.49x
Sector P/E	22.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	21.01%
EBITDA margin	24.31%
Effective tax rate	22.36%
FCF margin	13.71%
Gross margin	47.42%
Operating margin	21.01%
Pretax margin	20.99%
Profit margin	16.04%
Profit per employee	GBX 43,676
Profitable quarters	69
Profitable years	20
Revenue per employee	GBX 272,301
ROA	9.22%
ROA (5Y)	7.36%
ROCE	15.75%
ROE	14.71%
ROE (5Y)	12.27%
ROIC	14.31%
ROIC (5Y)	10.96%
Tax / revenue	4.69%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	28.9%
EPS growth (Q)	28.96%
EPS growth (QoQ)	-5.84%
EPS growth 10Y	16.04%
EPS growth 3Y	24.55%
EPS growth 5Y	13.57%
EPS growth quarters	12
EPS growth years	2
FCF growth	130.26%
FCF growth (Q)	188.55%
FCF growth (QoQ)	200.17%
FCF growth 3Y	36.82%
FCF growth 5Y	14.45%
Gross profit growth	18.35%
Gross profit growth (Q)	15.05%
Gross profit growth 3Y	15.68%
Gross profit growth 5Y	14.17%
Net income growth	28.9%
Net income growth (Q)	28.96%
Net income growth (QoQ)	-5.84%
Net income growth 3Y	24.55%
Net income growth 5Y	13.57%
Net income growth quarters	12
Net income growth years	2
OCF growth	74.86%
OCF growth (Q)	67.38%
OCF growth (QoQ)	11%
OCF growth 10Y	19.02%
OCF growth 3Y	23.47%
OCF growth 5Y	13.36%
Operating income growth	22.94%
Operating income growth (Q)	23.95%
Operating income growth 3Y	20.45%
Operating income growth 5Y	12.58%
Revenue growth	12.43%
Revenue growth (Q)	8.08%
Revenue growth (QoQ)	-2.7%
Revenue growth 10Y	15.32%
Revenue growth 3Y	12.4%
Revenue growth 5Y	13.79%
Revenue growth quarters	39
Revenue growth years	8

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	GBX -19.9M
Depreciation and amortization	GBX 10.7M
EBIT	GBX 70M
EBITDA	GBX 81M
EPS	GBX 0.07
Financing cash flow	GBX -28M
Free cash flow	GBX 44.7M
Gross profit	GBX 157.9M
Income taxes	GBX 15.6M
Investing cash flow	GBX -22.2M
Net borrowing	GBX -26.2M
Net cash flow	GBX 14.5M
Net income	GBX 53.4M
Operating income	GBX 70M
Revenue	GBX 333M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.3
Book value per share	GBX 0.83
Debt / EBITDA	0.24
Debt / equity	0.05
Debt / FCF	0.44
Goodwill	GBX 4.1M
Interest coverage	16.64
Long-term assets	GBX 316.4M
Long-term liabilities	GBX 49.2M
Net cash (debt)	GBX 16.2M
Net cash / market cap	4.18%
Net debt / EBITDA	-0.2
Net debt / equity	-0.04
Net debt / FCF	-0.36
Piotroski F-Score	8
Property, plant and equipment	GBX 273.7M
Shareholders' equity	GBX 395.8M
Tangible book value	GBX 337.7M
Tangible book value per share	GBX 0.76
Total assets	GBX 486.2M
Total cash	GBX 35.7M
Total debt	GBX 19.5M
Total liabilities	GBX 90.4M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.7
Current assets	GBX 169.8M
Current liabilities	GBX 41.2M
Current ratio	4.13
Inventory turnover	1.86
Net working capital	GBX 107.1M
Quick ratio	1.4
Working capital	GBX 131.3M
Working capital turnover	0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend growth	0%
Dividend growth (10Y)	13.67%
Dividend growth (3Y)	3.91%
Dividend growth (5Y)	-0.31%
Dividend growth years	1
Dividend payment years	1
Dividend payout frequency	Annual
Dividend per share	GBX 0.02
Dividend yield	4.41%
Ex-dividend date	2026-07-30
Last dividend	GBX 0.02
Payout ratio	2.45%
Shareholder yield	4.41%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	11.42%
10Y return CAGR	4.24%
10Y total return	51.44%
150-day SMA	GBX 49.38
15Y price change	280.92%
15Y return CAGR	12.41%
15Y total return	478.51%
1D price change	2.27%
1M price change	-8.4%
1M total return	-8.4%
1W price change	0.32%
1W total return	0.32%
1Y price change	22.49%
1Y return CAGR	28.29%
1Y total return	28.27%
20-day SMA	GBX 53.10
200-day SMA	GBX 48.44
20Y price change	183.34%
20Y return CAGR	7.86%
20Y total return	353.82%
3M price change	1.29%
3M total return	6.07%
3Y price change	36.81%
3Y return CAGR	17.27%
3Y total return	61.28%
50-day SMA	GBX 56.53
50-day SMA vs 200-day SMA	50over200
52-week high	GBX 65.00
52-week high date	2026-09-21
52-week low	GBX 36.70
52-week low date	2025-12-01
5Y price change	-43.97%
5Y return CAGR	-6.84%
5Y total return	-29.82%
All-time high	GBX 131.00
All-time high date	2022-01-04
All-time low	GBX 1.45
All-time low date	2009-03-12
Average true range (ATR)	GBX 1.97
Average volume	8.7K
Change from 52-week high	-18.97%
Change from 52-week low	43.52%
Change from all-time high	-59.79%
Change from all-time low	3,537.43%
Change from open	0%
Day's gap	2.27%
Dollar volume	GBX 790,050
High price	GBX 52.67
Low price	GBX 52.67
Monthly RSI	58.91
Open price	GBX 52.67
Previous close	GBX 51.50
Price vs 150-day SMA	6.67%
Price vs 20-day SMA	-0.81%
Price vs 200-day SMA	8.73%
Price vs 50-day SMA	-6.83%
Relative volume	1.64
RSI	40.17
Sharpe ratio	1.13
Sharpe ratio (3Y)	0.52
Sharpe ratio (5Y)	-0.07
Sortino ratio	2.24
Sortino ratio (3Y)	0.93
Sortino ratio (5Y)	0.05
Volume	15K
Weekly RSI	52.36
YTD price change	23.93%
YTD total return	29.78%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares change (QoQ)	0%
Shares held by institutions	0.08%

Deeper analysis on AIM/BXP

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this AIM/BXP report

Is a complete AIM/BXP research report available?

No complete published report is available for aim/BXP (AIM/BXP) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

AIM/BXP (AIM/BXP)

Price

Financial snapshot

Fair-value bridge

Latest news · AIM/BXP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AIM/BXP indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AIM/BXP

Frequently asked questions